WO2006077584A3 - Nouvelles formes cristallines d'aripiprazole - Google Patents

Nouvelles formes cristallines d'aripiprazole Download PDF

Info

Publication number
WO2006077584A3
WO2006077584A3 PCT/IL2006/000076 IL2006000076W WO2006077584A3 WO 2006077584 A3 WO2006077584 A3 WO 2006077584A3 IL 2006000076 W IL2006000076 W IL 2006000076W WO 2006077584 A3 WO2006077584 A3 WO 2006077584A3
Authority
WO
WIPO (PCT)
Prior art keywords
aripiprazole
crystalline forms
new crystalline
new
processes
Prior art date
Application number
PCT/IL2006/000076
Other languages
English (en)
Other versions
WO2006077584A2 (fr
Inventor
Itai Adin
Carmen Iustain
Original Assignee
Chemagis Ltd
Itai Adin
Carmen Iustain
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemagis Ltd, Itai Adin, Carmen Iustain filed Critical Chemagis Ltd
Publication of WO2006077584A2 publication Critical patent/WO2006077584A2/fr
Publication of WO2006077584A3 publication Critical patent/WO2006077584A3/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/22Oxygen atoms attached in position 2 or 4
    • C07D215/227Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention concerne de nouvelles formes cristallines d'aripiprazole et leurs procédés de préparation.
PCT/IL2006/000076 2005-01-18 2006-01-18 Nouvelles formes cristallines d'aripiprazole WO2006077584A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US64400405P 2005-01-18 2005-01-18
US60/644,004 2005-01-18

Publications (2)

Publication Number Publication Date
WO2006077584A2 WO2006077584A2 (fr) 2006-07-27
WO2006077584A3 true WO2006077584A3 (fr) 2006-12-07

Family

ID=36692619

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IL2006/000076 WO2006077584A2 (fr) 2005-01-18 2006-01-18 Nouvelles formes cristallines d'aripiprazole

Country Status (1)

Country Link
WO (1) WO2006077584A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7714129B2 (en) 2003-12-16 2010-05-11 Teva Pharmaceutical Industries Ltd. Methods of preparing anhydrous aripiprazole form II
CN102372672B (zh) * 2010-08-24 2014-06-04 重庆圣华曦药业股份有限公司 低吸湿性阿立哌唑晶体iv、制备方法及其应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060142299A1 (en) * 2004-11-18 2006-06-29 Ettema Gerrit J Crystalline aripiprazole solvates

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060142299A1 (en) * 2004-11-18 2006-06-29 Ettema Gerrit J Crystalline aripiprazole solvates

Also Published As

Publication number Publication date
WO2006077584A2 (fr) 2006-07-27

Similar Documents

Publication Publication Date Title
WO2007127834A3 (fr) Compositions et leurs méthodes d'élaboration
WO2005058835A3 (fr) Procedes de preparation de formes cristallines d'aripiprazole
WO2006127933A8 (fr) Procedes d'elaboration de forme i cristalline d'hydrochlorure de cinacalcet
WO2008066935A3 (fr) Formes cristallines de tigécycline et procédés de préparation de celles-ci
WO2006023627A8 (fr) Polymorphes de rapamycine et leurs utilisations
IL188330A0 (en) Processes for the preparation of
WO2006124713A3 (fr) 4-biarylyl-1-phenylazetidin-2-ones
WO2007133290A3 (fr) Anticorps anti-ox40l et méthodes correspondantes
WO2006119295A3 (fr) Compositions et methodes de traitement de maladies neurodegeneratives
WO2009025876A8 (fr) Formes cristallines de chlorhydrate d'erlotinib et formulations de celles-ci
WO2008127226A3 (fr) Antagonistes de kinase p13
WO2007127292A3 (fr) Formes cristallines de tigecycline et leurs procedes de preparation
WO2009067674A3 (fr) Polymorphes de base de sunitinib et procédés pour les préparer
SI1844036T1 (sl) Postopek za pripravo aripiprazola
WO2007076158A3 (fr) Procedes de preparation de bromhydrate de darifenacine
WO2008021342A3 (fr) Formes cristallines de la 9-hydroxy-rispéridone (palipéridone)
WO2010062715A3 (fr) Polymorphes de dasatinib et leur procédé de préparation
WO2007010555A3 (fr) Nouvelles formes cristallines d'hydrochlorure de moxifloxacine et procede de preparation associe
WO2005075427A3 (fr) Montelukast de sodium polymorphe
WO2008035373A3 (fr) Acide polysialique hautement pur et procédé d'élaboration
WO2007141593A3 (fr) Synthèse et préparations améliorées du métoprolol et de ses sels
WO2008088779A3 (fr) Formes solides de 5-azacytidine et procédés de préparation de ces dernières
WO2007127506A3 (fr) Anticorps anti-ephrinb2 et procédés les utilisant
WO2006090268A3 (fr) Procedes de preparation d'alfuzosine et de ses sels, nouvelles formes cristallines d'alfuzosine
WO2009002538A3 (fr) Erlotinib amorphe, procédés d'élaboration de l'erlotinib, et procédés d'élaboration d'autres formes d'erlotinib

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 06701415

Country of ref document: EP

Kind code of ref document: A2

WWW Wipo information: withdrawn in national office

Ref document number: 6701415

Country of ref document: EP